Status:
COMPLETED
Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?
Lead Sponsor:
University of British Columbia
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
19+ years
Phase:
NA
Brief Summary
Oxytocin is normally given either rapidly into the vein (bolus) or put into an intravenous bag and administered more slowly, after delivery of the baby by cesarean section. Both of these methods are c...
Detailed Description
Oxytocin is normally given either rapidly into the vein (bolus) or put into an intravenous bag and administered more slowly, after delivery of the baby by cesarean section. Both of these methods are c...
Eligibility Criteria
Inclusion
- Aged 19 years or over
- Having a cesarean section
- Have one or more of the following
- a larger than average uterus, because of
- a large baby
- twins, triplets, etc
- a large volume of fluid around the baby
- have received oxytocin to help stimulate labor for eight or more hours before cesarean section
- have infection inside the uterus that is treated with antibiotics
- bleeding after giving prior birth
- the placenta is in a position where it is more likely to bleed
- have had five or more pregnancies before current one
Exclusion
- Significant medical problem such that an oxytocin bolus might not be safe
- Active bleeding and their blood pressure or pulse rate are not normal
- Blood does not clot normally
- Aged less than 19 years
- Does not understand English
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00257803
Start Date
November 1 2005
End Date
December 1 2012
Last Update
March 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Women's Hospital, Department of Anesthesia
Vancouver, British Columbia, Canada